Sandoz Group AG (Sandoz Group AG) Price-to-Tangible-Book : (As of May. 26, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Price-to-Tangible-Book?

As of today (2024-05-26), Sandoz Group AG's share price is $34.995. Sandoz Group AG's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-1.18. Hence, Sandoz Group AG's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Sandoz Group AG's Price-to-Tangible-Book or its related term are showing as below:

SDZNY's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.32
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Sandoz Group AG's share price is $34.995. Sandoz Group AG's Book Value per Sharefor the quarter that ended in Dec. 2023 was $20.11. Hence, Sandoz Group AG's P/B Ratio of today is 1.74.

Sandoz Group AG Price-to-Tangible-Book Historical Data

The historical data trend for Sandoz Group AG's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Price-to-Tangible-Book Chart

Sandoz Group AG Annual Data

Trend

Dec22

Dec23

Price-to-Tangible-Book

Sandoz Group AG Quarterly Data
	Dec22	Dec23
Price-to-Tangible-Book	-	-

Competitive Comparison of Sandoz Group AG's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sandoz Group AG's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's Price-to-Tangible-Book falls into.

Sandoz Group AG Price-to-Tangible-Book Calculation

Sandoz Group AG's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	34.995	/	-1.177
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Sandoz Group AG Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Sandoz Group AG (Sandoz Group AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

SDZXF:USA SDZz:UK D8Y0:Germany SDZ:Switzerland

Address

Forum 1, Novartis Campus, Basel, CHE, CH-4056

Website

https://www.sandoz.com

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research • 02-14-2024